Inovio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Revenue	0.83	10.26	1.77	7.41	4.11	30.48	42.22	35.37	40.57	10.46	Upgrade
Revenue Growth (YoY)	-91.89%	478.23%	-76.05%	80.24%	-86.51%	-27.80%	19.37%	-12.83%	288.00%	-22.35%	Upgrade
Gross Profit	0.83	10.26	1.77	7.41	4.11	30.48	42.22	35.37	40.57	10.46	Upgrade
Selling, General & Admin	47.58	90.19	53.75	37.25	27.2	29.32	28.29	23.89	18.06	15.86	Upgrade
Research & Development	86.68	187.65	249.24	94.25	88.02	95.26	98.57	88.71	57.79	34.1	Upgrade
Other Operating Expenses	10.51	0	0	0	0	0	-1	-1	-1	0	Upgrade
Operating Expenses	144.77	277.84	302.99	131.49	115.22	124.57	125.86	111.6	74.86	49.95	Upgrade
Operating Income	-143.94	-267.57	-301.22	-124.08	-111.11	-94.09	-83.64	-76.24	-34.28	-39.5	Upgrade
Interest Expense / Income	1.22	1.25	1.94	8.7	7.95	0	0.03	0	0	0	Upgrade
Other Expense / Income	-10.05	10.99	0.5	33.63	0.56	0.71	4.54	-2.5	-3	-3.37	Upgrade
Pretax Income	-135.12	-279.82	-303.66	-166.41	-119.62	-94.8	-88.21	-73.74	-31.29	-36.12	Upgrade
Income Tax	0	0	0	0	-0.26	2.17	0	0	-2.1	0	Upgrade
Net Income	-135.12	-279.82	-303.66	-166.41	-119.36	-96.97	-88.21	-73.74	-29.19	-36.12	Upgrade
Shares Outstanding (Basic)	22	20	17	13	8	8	7	6	6	5	Upgrade
Shares Outstanding (Diluted)	22	20	17	13	8	8	7	6	6	5	Upgrade
Shares Change	11.51%	14.27%	34.62%	57.14%	6.68%	12.97%	11.89%	7.09%	15.08%	28.90%	Upgrade
EPS (Basic)	-6.09	-14.07	-17.45	-12.84	-14.52	-12.60	-12.96	-12.12	-5.16	-7.32	Upgrade
EPS (Diluted)	-6.09	-14.07	-17.45	-12.84	-14.52	-12.60	-13.08	-12.12	-5.28	-7.68	Upgrade
Free Cash Flow	-118.47	-217.18	-216.94	-179.5	-98.84	-75.64	-73.5	-66.49	-15.22	-31.2	Upgrade
Free Cash Flow Per Share	-5.34	-10.92	-12.47	-13.88	-12.02	-9.81	-10.79	-10.90	-2.68	-6.33	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-17300.28%	-2607.35%	-16972.34%	-1674.25%	-2702.10%	-308.68%	-198.11%	-215.55%	-84.50%	-377.71%	Upgrade
Profit Margin	-16239.87%	-2726.67%	-17109.87%	-2245.39%	-2902.75%	-318.12%	-208.92%	-208.49%	-71.94%	-345.44%	Upgrade
Free Cash Flow Margin	-14238.67%	-2116.34%	-12223.61%	-2422.00%	-2403.69%	-248.13%	-174.09%	-188.00%	-37.51%	-298.41%	Upgrade
EBITDA	-130.39	-273.07	-296.99	-153.08	-106.15	-89.8	-84.71	-70.65	-29.37	-34.55	Upgrade
EBITDA Margin	-15671.81%	-2660.89%	-16734.20%	-2065.53%	-2581.55%	-294.61%	-200.64%	-199.77%	-72.38%	-330.43%	Upgrade
Depreciation & Amortization	3.5	5.5	4.73	4.63	5.52	5	3.47	3.09	1.92	1.57	Upgrade
EBIT	-133.89	-278.56	-301.72	-157.71	-111.67	-94.8	-88.18	-73.74	-31.29	-36.12	Upgrade
EBIT Margin	-16092.90%	-2714.45%	-17000.76%	-2127.97%	-2715.71%	-311.00%	-208.86%	-208.49%	-77.11%	-345.44%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).